Medtronic
Medtronic Gains First FDA Approval to Conduct Early Feasibility Medical Device Study
February 26, 2013 10:06 am | by The Associated Press | News | CommentsMedtronic, Inc. announced that it has received U.S. Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Medtronic Native Outflow Tract Transcatheter Pulmonary Valve (TPV). This approval represents the first-ever FDA approval of an investigational device exemption (IDE) following the new draft FDA guidance for early feasibility studies.
Medtronic Adds to Intersect ENT's $30M Series D Round
February 25, 2013 12:52 pm | by Mass Device | News | CommentsMedtronic is once again backing sinus implant developer Intersect ENT, this time in a $30 million Series D round led by new investor Norwest Venture Partners. All of Intersect's existing "significant" backers participated in the latest round, including Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Medtronic, according to a press release.
Medtronic Cuts Estimated Medical Device Tax Impact in Half
February 19, 2013 5:07 pm | by Mass Device | News | CommentsMedtronic joins fellow medical device giants in forecasting lower 2013 medtech tax costs than previously anticipated. Medical device maker Medtronic (NYSE:MDT) this week became the latest in a string of medtech giants who have pared back their expectations of the impact of the 2.3% medical device sales tax.
Medtronic's Q3 Sales, Earnings Rise
February 19, 2013 8:17 am | by Mass Device | News | CommentsMedtronic posted profit and sales gains during its fiscal 3rd quarter this morning, eating Wall Street analysts' earnings expectations along the way. The Fridley, Minn.-based company, which is the world's largest pure-play medical device company, said profits were up 5.7% on sales growth of 2.8% for the 3 months ended Jan. 25.
Pacemaker Payment Plans, Courtesy of Medtronic
February 5, 2013 7:29 am | by Mass Device | News | CommentsMedtronic offers patients in India the option to pay off a pricey cardiac implants in installments. Medtronic's (NYSE:MDT) India division is offering patients an "easy monthly installment" plan to help families cope with the high cost of cardiac implants. The EMI program is available in 60 hospitals in 18 cities and applies to a handful of medical devices...
Device Tax: We Need Action by Summer, Paulsen Says
February 4, 2013 3:43 pm | by Mass Device | News | CommentsMedical device industry advocate Rep. Erik Paulsen (R-Minn.) says Congress needs to act on the medical device tax by "late spring, early summer" this year. Rep. Erik Paulsen (R-Minn.), an unrelenting opponent of the medical device tax that took effect at the start of the year, still sees avenues for repeal tied to larger discussions of corporate tax reform. News Well, Capitol Hill, Medical Device Taxread more
Biocompatibility and Performance of Medical Devices
January 2, 2013 2:19 pm | EventsJoin us for a rare gathering of international thought leaders sharing insights on crucial topics affecting our industries today. This comprehensive symposium is based on the definitive new publication “Biocompatibility and Performance of Medical Devices” assembled by ANSM expert Dr. Jean-Pierre Boutrand.
Biocompatibility and Performance of Medical Devices
January 2, 2013 2:15 pm | EventsJoin us for a rare gathering of international thought leaders sharing insights on crucial topics affecting our industries today. This comprehensive symposium is based on the definitive new publication “Biocompatibility and Performance of Medical Devices” assembled by ANSM expert Dr. Jean-Pierre Boutrand.
Singapore Pumps Innovation into the Heart of Asia’s Growing Cardio Device Industry
December 19, 2012 4:57 pm | by Kevin Lai | Blogs | CommentsIn the time it takes to read this piece, 30 Chinese men and women will die from heart disease. This staggering statistic means that as Asia continues to witness astonishing growth and development, Asians will increasingly wrestle with the disease. Heart disease is already the number one killer in China and India, and is fast on the rise throughout Southeast Asia, where the World Health Organization reports that cardiovascular diseases accounts for 27% of all deaths.
Medtronic’s Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneursym Repair
November 19, 2012 3:13 pm | by Medtronic | News | CommentsChosen for nearly one out of every two endovascular abdominal aortic aneurysm repairs worldwide, the Endurant AAA stent graft system from Medtronic, Inc. continues to show robust results in mid-term follow-up, according to two-year clinical data presented at VEITHsymposium, which concluded yesterday in New York.
Medtronic Engages Cardiologists in ‘World Diabetes Day’
October 24, 2012 11:24 am | by Medtronic | News | CommentsReinforcing its commitment to people with diabetes, Medtronic, Inc. (NYSE: MDT) is promoting its long-standing partnership with the International Diabetes Federation (IDF) through a new initiative surrounding “World Diabetes Day” on Nov. 14 that aims to engage interventional cardiologists worldwide in raising awareness of the connection between diabetes and coronary artery disease.
Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple Studies
October 23, 2012 11:44 am | by Medtronic | News | CommentsFor the treatment of long lesions and small vessels –– two challenging characteristics of coronary artery disease commonly found in patients with diabetes –– the Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) delivered successful clinical results, according to new data presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Medtronic Announces Approval and Launch of Japan’s First MR-Conditional Pacemaker System
October 18, 2012 12:32 pm | by Medtronic | News | CommentsMedtronic, Inc. (NYSE: MDT), today announced the Japanese regulatory approval and launch of the Advisa DR MRI™ SureScan™ pacing system. The Advisa MRI system is the first and only MR-Conditional pacemaker available to patients in Japan, the world’s second largest market for medical devices.
Medtronic reports first quarter earnings
August 23, 2012 6:09 am | by I-Micronews | News | CommentsThe Company reported worldwide first quarter revenue of $4.008 billion, an increase of 5 percent on a constant currency basis after adjusting for a $119 million negative foreign currency impact or 2 percent as reported. As reported, first quarter net earnings were $864 million, or $0.83 per diluted share...
M&A: The top 15 acquirers among medical device companies
August 6, 2012 3:37 pm | by Mass Device | News | CommentsA look at the most acquisitive medical device companies, culled from MassDevice.com's Big 100 database of more than 1,300 medical device industry transactions. More than $50 billion was spent on acquisitions by Big 100 medical device companies from the beginning of 2011 through the 1st half of 2012.
Medtronic wins expanded FDA indication for snoring implant | Regulatory Roundup
July 12, 2012 10:29 am | by Mass Device | News | CommentsMedtronic touts expanded indication for up to 5 implants of its Pillar Palatal devices to treat snoring. Medtronic obtains expanded indication for snoring treatment system...
Medtronic's Ishrak lands $25M in salary, benefits in 1st year
July 2, 2012 8:30 am | by Mass Device | News | CommentsMedtronic CEO Omar Ishrak's 1st-year take-home tops $25 million in salary, stock and bonuses that made up for benefits he gave up to take the job. MASSDEVICE ON CALL —Medtronic (NYSE:MDT) CEO Omar Ishrak's first year on the job netted him more than $25 million in salary, stock and bonuses that helped make up for the benefits he forfeited in order to take the jobs. Legal News, News Well, Healthcare Reform, On Call, Venture Capital/Private Equityread more
Medtronic Launches Endurant II AAA Stent Graft System in U.S.
June 7, 2012 7:55 am | News | CommentsMedtronic, Inc. has announced the U.S. launch of the Endurant® II AAA Stent Graft System, which recently received approval from the U.S. Food and Drug Administration (FDA) for the minimally invasive treatment of abdominal aortic aneurysms through endovascular repair...
Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
May 15, 2012 11:57 am | News | CommentsAs EuroPCR 2012 gets under way today, Medtronic, Inc. announced that the Resolute Integrity Coronary Stent System has received European regulatory approval for several new indications, making it the drug-eluting stent (DES) with the broadest range of approved indications...
Medtronic Named One of America's Best Corporate Citizens
April 25, 2012 5:38 am | News | CommentsMINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. is one of America's best corporate citizens, according to the rankings recently released by Corporate Responsibility magazine. Medtronic made the top 50 list, moving up 16 spots from its 66th ranking in 2011.
Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
April 13, 2012 7:19 am | News | CommentsMINNEAPOLIS –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the evidence to support their adoption, Medtronic, Inc. announced today the start of the Medtronic IN.PACT SFA II study, the company’s first...
Medtronic Reaches Settlement of Shareholder Class Action
April 2, 2012 5:26 am | News | CommentsMINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. today announced that the company has reached an agreement in principle to settle a previously disclosed federal securities class action. Under the settlement, the company will make a payment of $85 million to resolve all of the class claims.
Medtronic Receives CE Mark for Pacemaker Lead That Will Expand Patient Access to MRI Technology
March 6, 2012 4:54 am | News | CommentsMedtronic, Inc. today announced the receipt of CE Mark (Conformité Européenne) and launch of the CapSure Sense MRI™ SureScan® pacing leads, which are approved for use during Magnetic Resonance Imaging (MRI). Medtronic introduced the first MR-Conditional pacemaker system in the world in 2008 and in the U.S. in 2011.
Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
February 9, 2012 5:09 am | News | CommentsMINNEAPOLIS--(BUSINESS WIRE)--Consistent with its commitment to developing better treatments for peripheral arterial disease (PAD), Medtronic Inc. today announced the one-year results of an international study of the Complete SE (self-expanding) vascular stent for the treatment of atherosclerosis...
Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting
February 2, 2012 5:12 am | News | CommentsMINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. today announced the initiation and first patient enrollment in a clinical study that will evaluate gaps in the implementation of evidence-based treatment guidelines among chronic heart failure patients post-hospital discharge.
